Houston TX 狼疮性肾炎临床试验
8项针对 狼疮性肾炎的研究正在 Houston及周边约 30 英里内的站点招募参与者。打开研究详情可查看入选标准及联系研究团队的方式。
官方研究文本（英文）
正在为研究招募参与者？将此页面置顶展示 — $99 / 30天 →
Dose Escalation Study With Bispecific Antibodies in Adult Participants With Lupus Nephritis
招募中1 期
- Baylor College of Medicine, Houston
The Pediatric Lupus Nephritis Mycophenolate Mofetil (PLUMM) Study
招募中2 期
- Baylor College of Medicine Pediatric Immunology Allergy Rheumatology, Houston
RESET-SLE: A Phase 1/2 Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Systemic Lupus Erythematosus
招募中1/2 期
- University of Texas MD Anderson Cancer Center, Houston
PRESERVE: LUPKYNIS in Combination With Belimumab, Obinutuzumab or Anifrolumab in Patients With Lupus Nephritis
招募中4 期
- Northwest Houston Arthritis Center, Houston
- Novel Research LLC, Bellaire · 距离 7 英里
Study of Efficacy and Safety of LNP023 in Participants With Active Lupus Nephritis Class III-IV, +/- V
招募中2 期
- Prolato Clinical Research Center, Houston
A Research Trial to Assess if Cenerimod is Efficacious and Safe to Treat Active Lupus Nephritis on Top of Regular Treatment
招募中3 期
- Novel Research, LLC., Houston
- Northwest Houston Arthritis, Houston
- Rheumatology Care Center, PLLC, Bellaire · 距离 7 英里
A Phase 1/2 Study of NKX019 in Subjects With Autoimmune Disease (Ntrust-1)
招募中1/2 期
- Nkarta Investigational Site, Houston
Phase I/II Study of AD-PluReceptor Plus Tafasitamab-cxix and Lymphodepleting Chemotherapy in Patients With Autoimmune Disorders
招募中1/2 期
- MD Anderson Cancer Center, Houston
- The University of Texas Health Science Center at Houston, Houston
其他城市的 狼疮性肾炎试验
- New York City, NY10 项研究
- Atlanta, GA9 项研究
- Chicago, IL9 项研究
- Durham, NC8 项研究
- Philadelphia, PA7 项研究
- San Francisco, CA7 项研究
- Boston, MA7 项研究
- Aurora, CO5 项研究
- St. Louis, MO5 项研究
- Miami, FL5 项研究
- Jacksonville, FL4 项研究
- Charleston, SC4 项研究
Houston的其他研究
- 非小细胞肺癌145 项研究
- 乳腺癌126 项研究
- 癌症（所有类型）122 项研究
- 转移性癌症104 项研究
- 结直肠癌103 项研究
- 卵巢癌90 项研究
- 急性髓系白血病86 项研究
- 肺癌78 项研究
- 前列腺癌76 项研究
- 子宫内膜癌69 项研究
- 胰腺癌62 项研究
- 黑色素瘤59 项研究
数据来自 ClinicalTrials.gov，检索日期：2026年10月1日。每项研究自行设定入选标准，由研究团队决定谁能参与。